Resistance to Fluoroquinolone by a Combination of Efflux and Target Site Mutations in Enteroaggregative Escherichia coli Isolated in Korea

Osong Public Health and Research Perspectives

Volumn 3, Issue 4, 2012, Pages 239-244

  Kim, Jun Young ^a   Jeon, Se Mi ^a   Kim, Hyungjun ^a   Lim, Nara ^a   Park, Mi Sun ^a   Kim, Seong Han ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

Aac(6') Ib cr; Efflux pump; Enteroaggregative Escherichia coli; Fluoroquinolone; GyrA; ParC; Qnr

Indexed keywords

CIPROFLOXACIN; NORFLOXACIN; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENTEROAGGREGATIVE ESCHERICHIA COLI; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GYRA GENE; KOREA; MDFA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TOLC GENE; YDHE GENE;

EID: 84872128884     PISSN: 22109099     EISSN: 22109110     Source Type: Journal    
DOI: 10.1016/j.phrp.2012.11.002     Document Type: Article

References (23)

1. Cerna J.F., Nataro J.P., Estrada-Garcia T. Multiplex PCR for detection of three plasmid-borne genes of enteroaggregative Escherichia coli strains. J Clin Microbiol. 2003 May, 41(5):2138-2140.
2. Nataro J.P., Deng Y., Maneval D.R., et al. Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect Immun 1992 Jun, 60(6):2297-2304.
3. Swick M.C., Morgan-Linnell S.K., Carlson K.M., et al. Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother 2011 Feb, 55(2):921-924.
4. Kaur P., Chakraborti A., Asea A. Enteroaggregative Escherichia coli: an emerging enteric food borne pathogen. Interdiscip Perspect Infect Dis 2010, 2010:254159.
5. Yamamoto T., Nakazawa M. Detection and sequences of the enteroaggregative Escherichia coli heat-stable enterotoxin 1 gene in enterotoxigenic E. coli strains isolated from piglets and calves with diarrhea. J Clin Microbiol. 1997 Jan, 35(1):223-227.
6. Dudley E.G., Abe C., Ghigo J.M., et al. An IncI1 plasmid contributes to the adherence of the atypical enteroaggregative Escherichia coli strain C1096 to cultured cells and abiotic surfaces. Infect Immun 2006 Apr, 74(4):2102-2114.
7. Jiang Z.D., Greenberg D., Nataro J.P., et al. Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers. J Clin Microbiol. 2002 Nov, 40(11):4185-4190.
8. Ochoa T.J., Ruiz J., Molina M., et al. High frequency of antimicrobial drug resistance of diarrheagenic Escherichia coli in infants in Peru. Am J Trop Med Hyg 2009 Aug, 81(2):296-301.
9. Aslani M.M., Alikhani M.Y., Zavari A., et al. Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern. Int J Infect Dis 2011 Feb, 15(2):e136-e139.
10. Drlica K., Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997 Sep, 61(3):377-392.
11. Robicsek A, Jacoby GA, Hooper DC The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 2006 Oct, 6(10):629-640.
12. Poole K. Efflux-mediated multiresistance in gram-negative bacteria. Clin Microbiol Infect 2004 Jan, 10(1):12-26.
13. Oethinger M., Kern W.V., Jellen-Ritter A.S., et al. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 2000 Jan, 44(1):10-13.
14. Baucheron S., Imberechts H., Chaslus-Dancla E., et al. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204. Microb Drug Resist 2002, 8(4):281-289. Winter.
15. Kim J.Y., Kim S.H., Jeon S.M., et al. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea. Clin Microbiol Infect 2008 Aug, 14(8):760-765.
16. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing. 21st informational supplement M100-S21 2011, CLSI, Wayne, PA.
17. Truong Q.C., Nguyen Van J.C., Shlaes D., et al. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics. Antimicrob Agents Chemother 1997 Jan, 41(1):85-90.
18. Ricci V., Piddock L. Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones. J Antimicrob Chemother 2003 Oct, 52(4):605-609.
19. Giulietti A., Overbergh L., Valckx D., et al. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001 Dec, 25(4):386-401.
20. Vila J., Ruiz J., Goñi P., et al. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1996 Feb, 40(2):491-493.
21. Pao S.S., Paulsen I.T., Saier M.H. Major facilitator superfamily. Microbiol Mol Biol Rev. 1998 Mar, 62(1):1-34.
22. Fralick J.A. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J Bacteriol 1996 Oct, 178(19):5803-5805.
23. Ma D., Cook D.N., Hearst J.E., et al. Efflux pumps and drug resistance in gram-negative bacteria. Trends Microbiol. 1994 Dec, 2(12):489-493.